Statistical Approach to COVID-19 Clinical Trials Aims to Accelerate Drug Approval Process

In response to the COVID-19 pandemic, researchers from the Massachusetts Institute of Technology have published a pair of studies in a COVID-19 special issue of the Harvard Data Science Review, freely available via open access, describing new methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for clinical trials of vaccines and other anti-infective therapies.
Source: eHealth News EU - Category: Information Technology Tags: Featured Research Research and Development Source Type: news